Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195051 · ClinicalTrials.gov registry record · Phase 3
Medication Reconciliation Technology to Improve Quality of Transitional Care
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,818
- Enrollment target
NCT01195051: Completed Phase 3 study, sponsored by Indiana University.
NCT01195051 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 4,818 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (524% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01195051, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,818 participants
- Enrollment target
Study Summary
This study addresses the problem of inadequate medication reconciliation as patients cross boundaries between inpatient and outpatient care (ambulatory care). The purpose of this study is to determine whether a new, computer-based application, integrated with electronic prescribing, improves erroneous discrepancies between pre-hospital medications and medications upon patients' return to ambulatory care.
Primary Outcome
Number and fraction of outpatient medications prescribed or addressed as to why prescribing did not occur. Number and fraction of cases with MR by a pharmacist. Number and fraction of cases undergoing any MR. Number and fraction of cases where any outpatient medications were not prescribed or addressed as to why prescribing did not occur.
Interventions
- OTHER Electronic medication reconciliation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,818 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
What the finished NCT01195051 record still lists
NCT01195051 is an interventional study that assigns participants to a tested intervention. Its 4,818 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (524% higher).
The record links to 0 conditions, and to 1 intervention - of which Electronic medication reconciliation is the first listed.
NCT01195051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01195051 about?
NCT01195051 is a clinical study titled "Medication Reconciliation Technology to Improve Quality of Transitional Care". This study addresses the problem of inadequate medication reconciliation as patients cross boundaries between inpatient and outpatient care (ambulatory care). The purpose of this study is to determine whether a new, computer-based application, integrated with electronic prescribing, improves erroneo...
What is the current status of trial NCT01195051?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,818 participants. The study started on 2010-11. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01195051?
The interventions under investigation include: Electronic medication reconciliation (OTHER).
Who is sponsoring clinical trial NCT01195051?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01195051's enrollment target sits among peer trials
4,818 53rd of 2000 higher than 1,948 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia